Apellis Pharmaceuticals Inc (APLS)
41.30
-0.70
(-1.67%)
USD |
NASDAQ |
May 17, 16:00
41.30
0.00 (0.00%)
After-Hours: 20:00
Apellis Pharmaceuticals Cash from Operations (TTM): -550.10M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -550.10M |
December 31, 2023 | -594.74M |
September 30, 2023 | -637.60M |
June 30, 2023 | -622.94M |
March 31, 2023 | -579.80M |
December 31, 2022 | -513.74M |
September 30, 2022 | -485.50M |
June 30, 2022 | -499.71M |
March 31, 2022 | -521.37M |
December 31, 2021 | -563.13M |
September 30, 2021 | -308.65M |
June 30, 2021 | -239.85M |
March 31, 2021 | -205.45M |
Date | Value |
---|---|
December 31, 2020 | -160.49M |
September 30, 2020 | -384.54M |
June 30, 2020 | -338.31M |
March 31, 2020 | -283.92M |
December 31, 2019 | -211.14M |
September 30, 2019 | -173.54M |
June 30, 2019 | -153.08M |
March 31, 2019 | -143.87M |
December 31, 2018 | -131.24M |
September 30, 2018 | -102.30M |
June 30, 2018 | -80.30M |
March 31, 2018 | -61.10M |
December 31, 2017 | -46.60M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-637.60M
Minimum
Sep 2023
-153.08M
Maximum
Jun 2019
-401.38M
Average
-435.02M
Median
Cash from Operations (TTM) Benchmarks
Inspire Medical Systems Inc | 34.86M |
Sarepta Therapeutics Inc | -533.67M |
Blueprint Medicines Corp | -415.40M |
Alnylam Pharmaceuticals Inc | 189.12M |
Cytokinetics Inc | -421.55M |